Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC

Clinical trial NCT03726736 · UNKNOWN

Trial details

NCT number: NCT03726736
Sponsor: Yong Fang
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2018-12-21
Primary completion: 2019-11-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.